查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1250696

全球 Ubiotics 市場：到 2028 年的預測——按產品、形式、牲畜、應用、最終用戶和地區分析

Eubiotics Market Forecasts to 2028 - Global Analysis By Product, Form, Livestock, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2022 年全球益生菌市場規模將達到 50.9 億美元，預計 2028 年將達到 93.7 億美元，預測期內復合年增長率為 10.7%。

Eubiotics 由飼料廠、預混器或某些分銷商製造和銷售。Eubiotics 由直接銷售給消費者或整合飼料製造商的企業生產。在這兩種情況下，農民都會收到 Eubiotics 產品。Eubiotics 使用發酵和化學合成等技術來製造有機酸。

據世界銀行稱，採用工業化肉類生產的增長速度是傳統肉類生產的六倍。據世界衛生組織稱，美國每年約有 200 萬人遭受抗生素耐藥性感染，導致約 23,000 人死亡。

市場動態：

促進者

牲畜疾病增加

有利於這個市場的主要因素之一是全球牲畜疾病的增加。以益生元為基礎的飲食餵養的動物不僅可以獲得重要的營養素，而且還具有健康和治療益處，例如慢性病的早期發現和治療。此外，消費者對飼料質量和安全意識的增強也有助於擴大市場。在動物和家畜中，益生菌經常被用作抗生素生長促進劑 (AGP) 的替代品。相應地，對動物蛋白和肉類的需求不斷增長，也推動了對益生菌不斷增長的需求。動物作為寵物的馴化和畜牧業的快速現代化，特別是在發達國家，預計將成為進一步的促成因素。

抑製劑

對生態學的無知

一些國家禁止使用抗生素，但它們仍在畜牧業中使用。此外，過度使用抗生素會促進抗菌素耐藥性 (AMR) 的發展。具有抗菌素耐藥性 (AMR) 的動物對治療沒有反應，這使得疾病更難治療，並增加了疾病傳播、嚴重疾病和死亡的風險。不幸的是，許多農民不願意改用益生菌，因為他們不知道抗生素的有害影響。因此，缺乏關於益生菌益處的知識是一個主要的商業風險。

機會

一種稱為 eubiotics 的新替代方法

最近的科學發現表明，共生素（益生菌 + 益生元）在家禽飲食中促進健康並提高動物生產力。源自植物多酚的芳香化合物具有抗氧化能力並抑制細菌胞外□和氧化磷酸化，有助於防止感染利用代謝底物和吸收營養。這個動作提高了身體的免疫反應。由於對健康動物飼料添加劑的重要性有了更深入的了解，Eubiotics 在世界範圍內得到越來越廣泛的採用。

威脅

原材料價格飆升

原材料成本上漲已成為全球飼料生產商面臨的主要問題。益生元來自有機材料，如種子、樹皮和樹葉。益生菌市場受到有關生物廢物原料和廢水處理的嚴格法規以及這些原料不斷上升的提取成本的限制。隨著世界人口的增長和由此產生的食品需求的增加，動物飼料行業面臨著確保玉米、小麥和大麥等飼料原料安全的巨大壓力。此外，植物提取物和精油等原料新用於醫藥和化妝品，其成本也在上升。由此，飼料添加劑生產企業承擔的運營成本也在不斷攀升。這些因素可能會在預期期間限制市場擴張。

COVID-19 的影響

益生菌行業受到 COVID-19 爆發的輕微影響。由於主要市場的流動受到嚴格限制，企業遭受了財務損失，但對整個行業的影響喜憂參半。然而，此次疫情提高了公眾對食用動物使用抗生素危害的認識，這對益生菌業務的增長產生了積極影響。COVID-19 已導致全球工廠、生產和製造設施、餐廳、住宿設施等關閉。結果，出現了勞動力短缺、供應鏈中斷和原材料供應減少的情況。

有機酸部分預計在預測期內將是最大的

據估計，有機酸領域將有有利可圖的增長。這些酸在動物營養中用作飼料和穀物防腐劑。通過防止黴菌和細菌感染的發展，幫助提高飼料資源的利用率。可應用於家禽、水產養殖、養豬等項目。有機酸的使用已被證明可有效解決飼料質量和衛生問題。所有這些特徵預計將在預測期內推動有機酸部門的增長。

腸道環境部分預計在預測期內復合年增長率最高

由於動物經常有消化問題和預防保健的日益普及，預計腸道環境部分在預測期內將見證最快的複合年增長率。Eubiotics 產品將微生物群集中在動物的胃腸道內，有助於改善消化和免疫系統。可以改善腸道完整性，尤其是通過使用益生菌、有機酸和精油等產品。這些產品可以單獨使用或組合使用以獲得更好的效果。

市場佔有率最高的地區

在預測期內，北美預計將佔據最大的市場份額。這是因為益生菌在畜牧業領域的使用越來越多。由於該地區存在多家益生菌製造公司，預計該市場也將增長。對動物製成的產品的需求不斷增長，以及政府為保護畜牧業而製定的不斷擴大的法規正在推動北美市場的增長，其次是歐洲。由於對益生菌替代品的負面影響的高度認識，該地區的農民也在採用益生菌來餵養牲畜並滿足需求。

複合年增長率最高的地區：

預計歐洲在預測期內的複合年增長率最高，這是由於對益生菌益處的普遍認識提高、嚴格法規的實施以及抗生素的禁令。高質量飼料添加劑的採用以及對動物健康和安全的日益關注正在推動該地區益生菌市場的增長。技術改進、研發支出和主要參與者的存在進一步加強了歐洲市場。

重大發展

2021 年 7 月，活躍於材料、健康和營養領域的荷蘭跨國公司 Koninklijke DSM NV 將開發創新的靶向益生菌，將顯著改善環境影響和動物健康。宣布已收購生物技術公司 Midori USA, Inc.初創公司。

2021年1月，領先的畜牧業營養與健康解決方案供應商Novus International, Inc.將藉助研發合作和解決方案擴大客戶群，開發原始和創意產品，宣布與Massachusetts biotech建立合作夥伴關係創新者 Agrivida。

本報告提供的內容

  • 區域和國家細分市場份額評估
  • 對新進入者的戰略建議
  • 涵蓋 2020、2021、2022、2025 和 2028 年的市場數據
  • 市場驅動因素（市場趨勢、制約因素、機會、威脅、挑戰、投資機會/建議等）
  • 基於市場估計的關鍵業務領域的戰略建議
  • 競爭格局和趨勢
  • 公司概況，包括詳細戰略、財務狀況和近期發展
  • 供應鏈趨勢反映了最新的技術進步。

提供免費定制

購買此報告的客戶將免費獲得以下定制之一。

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 個）
    • 主要參與者的 SWOT 分析（最多 3 人）
  • 區域部分
    • 應客戶要求提供主要國家的市場預估、預測和CAGR（注：通過可行性檢查）
  • 競爭標桿
    • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

目錄

第一章內容提要

第二章前言

  • 概述
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 研究來源
    • 主要研究來源
    • 二手研究資源
    • 假設

第三章市場趨勢分析

  • 促進者
  • 抑製劑
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5 全球 Ubiotics 市場，按產品

  • 益生元
    • 低聚果糖 (FOS)
    • 低聚半乳糖 (GOS)
    • 菊粉
    • 甘露寡糖 (MOS)
  • 益生菌
    • 鏈球菌
    • 乳酸菌
    • 雙歧桿菌
  • 有機酸
    • 醋酸
    • 富馬酸
    • 甲酸
    • 乳酸
    • 丙酸
  • 香精油
  • 酵素
  • 致戰鬥力
  • 其他產品

6 全球益生菌市場：按形式分類

  • 液體
  • 堅硬的

7. 全球 Eubiotics 市場，按牲畜分類

  • 家禽
  • 豬
  • 反芻動物
  • 水生動物
  • 其他牲畜

9 全球 Ubiotics 市場，按應用

  • 免疫
  • 腸道健康
  • 屈服
  • 營養
  • 其他用途

10. 全球 Ubiotics 市場，按最終用戶分類

  • 家禽飼料
  • 牲畜飼料
  • 豬飼料
  • 水產飼料
  • 其他最終用戶

11. 全球 Ubiotics 市場，按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東

第十二章主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第十三章公司簡介

  • BEHN MEYER
  • DSM
  • Novus International, Inc.
  • Advanced BioNutrition Corp
  • Lallemand, Inc.
  • DuPont de Nemours, Inc.
  • Associated British Foods plc
  • Novozymes
  • Calpis Co., Ltd.
  • UAS Laboratories
  • BENEO
  • Koninklijke DSM N.V
  • Lesaffre Group
  • Evonik Industries AG
  • Chr. Hansen Holding A/S
  • Cargill, Incorporated
  • BASF SE
  • Biomin
  • ADM
  • Bluestar Adisseo Co.
Product Code: SMRC22573

According to Stratistics MRC, the Global Eubiotics Market is accounted for $5.09 billion in 2022 and is expected to reach $9.37 billion by 2028 growing at a CAGR of 10.7% during the forecast period. Eubiotics are manufactured and distributed by feed mills, pre-mixers, or particular distributors. Eubiotics are produced by businesses that either offers their goods directly to consumers or to integrate feed producers. In any case, the animal farmers receive the Eubiotics products. Eubiotics are produced using techniques like fermentation and chemical synthesis to create organic acids.

According to the World Bank, the adoption of industrialized meat production is growing 6 times faster than that of traditional meat production. According to WHO, about 2 million people in the U.S. suffer from antibiotic resistant infections each year while death toll reaches nearly 23,000.

Market Dynamics:

Driver:

Increasing prevalence of livestock diseases

One of the main elements fostering a favourable view for the market is the rising occurrence of livestock diseases around the world. Animals fed on feed based on eubiotics receive critical nutrients as well as health and therapeutic advantages, such as the early detection and treatment of chronic disorders. Also, rising consumer awareness of feed quality and safety is contributing to market expansion. In animals and livestock, eubiotics are frequently employed as an alternative to antibiotic growth promoters (AGPs). In accordance with this, the rising demand for Eubiotics is also being fuelled by the rising need for animal protein and meat. Additional causes, particularly in industrialised nations, are projected to push the domestication of animals as pets and the quick modernization of the cattle business.

Restraint:

Unawareness about eubiotics

Although being outlawed in some countries, antibiotics are nonetheless utilised in the livestock industry. Moreover, overusing antibiotics can encourage the development of antimicrobial resistance (AMR). Animals that develop antimicrobial resistance (AMR) do not respond to treatment, making illnesses harder to treat and raising the risk of disease transmission, serious illness, and death. Unfortunately, many farmers are reluctant to transition to eubiotics because they are unaware of the harmful effects of antibiotics. Therefore, a major commercial danger is the lack of knowledge about the advantages of eubiotics.

Opportunity:

New alternative approach of eubiotics

Recent scientific discoveries suggest that symbiotic (probiotics + prebiotics) can promote a healthy and increased rate of animal production in poultry diets. Aromatic compounds derived from plant polyphenols that have antioxidant capabilities and suppress bacterial extracellular enzymes and oxidative phosphorylation aid in preventing infections from utilising their metabolic substrates and absorbing nutrients. The body's immunological responses are improved by this function. Eubiotics are being adopted more widely across the globe as a result of growing understanding of the significance of healthy animal feed additives.

Threat:

Rising raw material prices

Increasing raw material costs are a significant issue for feed producers all over the world. Eubiotics come from organic materials like seeds, bark, and leaves. The market for eubiotics is being constrained by increasing extraction costs from these sources as well as strict rules on bio-waste materials and wastewater treatment. The animal feed industry is under a lot of pressure to find raw feeds like corn, wheat, and barley as the world's population rises and the resulting demand for food rises. Also, the cost of raw ingredients like plant extracts and essential oils is rising as a result of their new uses in pharmaceutical and cosmetic products. As a result, the operating expenses incurred by producers of feed additives are also rising. These elements will restrict market expansion during the anticipated term.

Covid-19 Impact

The eubiotics industry has been slightly impacted by the COVID-19 epidemic. Although firms have suffered financial losses as a result of significant mobility restrictions in significant markets, the industry's overall impact is mixed. The pandemic has, however, increased public awareness of the harmful effects of antibiotics in food animals, which has positively impacted the growth of the Eubiotics business. Worldwide closures of factories, production and manufacturing facilities, eateries, lodging facilities, and other businesses were brought on by COVID-19. This led to a lack of labour, a breakdown in the supply chain, and a decrease in the supply of raw materials and other supplies.

The organic acids segment is expected to be the largest during the forecast period

The organic acids segment is estimated to have a lucrative growth. These acids are employed in animal nutrition as forage and grain preservatives. They help to improve the utilisation of feed resources by preventing the formation of mould and bacterial infections. They can be applied to projects including poultry, aquaculture, and pigs. The use of organic acids has shown to be a successful remedy for problems with feed quality and sanitation. Over the course of the projection period, all these characteristics are anticipated to fuel segment growth for organic acids.

The gut health segment is expected to have the highest CAGR during the forecast period

The gut health segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the fact that animals frequently experience problems with their digestive systems as well as the rising popularity of preventative healthcare. Eubiotics products aid in aggregating the microbiota production in the animal's digestive tract, improving digestion and the immune system. Gut integrity can be improved by using products like probiotics, probiotics, organic acids, and essential oils, among others. To get better results, these products can be used separately or in combination.

Region with highest share:

North America is projected to hold the largest market shares during the forecast period owing to eubiotics are being used more and more in the livestock field industry. Also, the existence of multiple eubiotics manufacturing enterprises in this area is anticipated to foster the market's expansion there. Due to the rising demand for products made from animals and the expansion of government regulation to safeguard the animal husbandry industry, Europe is now following North America. Also, farmers in this area are employing eubiotics to raise their livestock and meet demand because they are more aware of the negative effects of alternatives to eubiotics.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to rising public knowledge of the advantages of eubiotics, the implementation of strict restrictions, and a ban on the use of antibiotics. The adoption of high-quality feed additives in this region, together with growing concerns about animal health and safety, are driving the expansion of the eubiotics market. The market in Europe has been further bolstered by technical improvements, expenditures in research & development, and the presence of major companies.

Key Players in the market

Some of the key players profiled in the Eubiotics Market include BEHN MEYER, DSM, Novus International, Inc., Advanced BioNutrition Corp, Lallemand, Inc., DuPont de Nemours, Inc., Associated British Foods plc, Novozymes, Calpis Co., Ltd., UAS Laboratories, BENEO, Koninklijke DSM N.V, Lesaffre Group, Evonik Industries AG, Chr. Hansen Holding A/S, Cargill, Incorporated, BASF SE, Biomin, ADM and Bluestar Adisseo Co.

Key Developments:

In July 2021, Koninklijke DSM N.V, a Netherlands-based multinational corporation that is engaged in the fields of materials, health, and nutrition, announced that they have acquired Midori USA, Inc., a biotechnological start-up company that is engaged in developing innovative targeted eubiotics that significantly enhance the environmental impact and health of the animals.

In January 2021, Novus International, Inc., a dominant player that provides nutrition and health solutions in the animal agriculture industry, announced that they have partnered with Agrivida, a Massachusetts-based biotech innovator, in order to expand their customer base as well as implore pristine and creative products and solutions with the help of R&D collaboration.

Products Covered:

  • Prebiotics
  • Probiotics
  • Organic Acids
  • Essential Oil
  • Enzymes
  • Phytogenic
  • Other Products

Forms Covered:

  • Liquid
  • Solid

Livestock's Covered:

  • Poultry
  • Swine
  • Ruminants
  • Aquatic Animals
  • Other Livestock's

Applications Covered:

  • Immunity
  • Gut Health
  • Yield
  • Nutrition
  • Other Applications

End Users Covered:

  • Poultry Feed
  • Cattle Feed
  • Swine Feed
  • Aquatic Feed
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Eubiotics Market, By Product

  • 5.1 Introduction
  • 5.2 Prebiotics
    • 5.2.1 Fructo-oligosaccharides (FOS)
    • 5.2.2 Galacto-Oligosaccharides (GOS)
    • 5.2.3 Inulin
    • 5.2.4 Mannan-Oligosaccharides (MOS)
  • 5.3 Probiotics
    • 5.3.1 Streptococcus
    • 5.3.2 Lactobacilli
    • 5.3.3 Bifidobacterum
  • 5.4 Organic Acids
    • 5.4.1 Acetic Acid
    • 5.4.2 Fumaric Acid
    • 5.4.3 Formiv Acid
    • 5.4.4 Lactic Acid
    • 5.4.5 Propionic Acid
  • 5.5 Essential Oil
  • 5.6 Enzymes
  • 5.7 Phytogenic
  • 5.8 Other Products

6 Global Eubiotics Market, By Form

  • 6.1 Introduction
  • 6.2 Liquid
  • 6.3 Solid

7 Global Eubiotics Market, By Livestock

  • 7.1 Introduction
  • 7.2 Poultry
  • 7.3 Swine
  • 7.4 Ruminants
  • 7.5 Aquatic Animals
  • 7.6 Other Livestocks

9 Global Eubiotics Market, By Application

  • 9.1 Introduction
  • 9.2 Immunity
  • 9.3 Gut Health
  • 9.4 Yield
  • 9.5 Nutrition
  • 9.6 Other Applications

10 Global Eubiotics Market, By End User

  • 10.1 Introduction
  • 10.2 Poultry Feed
  • 10.3 Cattle Feed
  • 10.4 Swine Feed
  • 10.5 Aquatic Feed
  • 10.6 Other End Users

11 Global Eubiotics Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 BEHN MEYER
  • 13.2 DSM
  • 13.3 Novus International, Inc.
  • 13.4 Advanced BioNutrition Corp
  • 13.5 Lallemand, Inc.
  • 13.6 DuPont de Nemours, Inc.
  • 13.7 Associated British Foods plc
  • 13.8 Novozymes
  • 13.9 Calpis Co., Ltd.
  • 13.10 UAS Laboratories
  • 13.11 BENEO
  • 13.12 Koninklijke DSM N.V
  • 13.13 Lesaffre Group
  • 13.14 Evonik Industries AG
  • 13.15 Chr. Hansen Holding A/S
  • 13.16 Cargill, Incorporated
  • 13.17 BASF SE
  • 13.18 Biomin
  • 13.19 ADM
  • 13.20 Bluestar Adisseo Co.

List of Tables

  • Table 1 Global Eubiotics Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Eubiotics Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Eubiotics Market Outlook, By Prebiotics (2020-2028) ($MN)
  • Table 4 Global Eubiotics Market Outlook, By Fructo-oligosaccharides (FOS) (2020-2028) ($MN)
  • Table 5 Global Eubiotics Market Outlook, By Galacto-Oligosaccharides (GOS) (2020-2028) ($MN)
  • Table 6 Global Eubiotics Market Outlook, By Inulin (2020-2028) ($MN)
  • Table 7 Global Eubiotics Market Outlook, By Mannan-Oligosaccharides (MOS) (2020-2028) ($MN)
  • Table 8 Global Eubiotics Market Outlook, By Probiotics (2020-2028) ($MN)
  • Table 9 Global Eubiotics Market Outlook, By Streptococcus (2020-2028) ($MN)
  • Table 10 Global Eubiotics Market Outlook, By Lactobacilli (2020-2028) ($MN)
  • Table 11 Global Eubiotics Market Outlook, By Bifidobacterum (2020-2028) ($MN)
  • Table 12 Global Eubiotics Market Outlook, By Organic Acids (2020-2028) ($MN)
  • Table 13 Global Eubiotics Market Outlook, By Acetic Acid (2020-2028) ($MN)
  • Table 14 Global Eubiotics Market Outlook, By Fumaric Acid (2020-2028) ($MN)
  • Table 15 Global Eubiotics Market Outlook, By Formiv Acid (2020-2028) ($MN)
  • Table 16 Global Eubiotics Market Outlook, By Lactic Acid (2020-2028) ($MN)
  • Table 17 Global Eubiotics Market Outlook, By Propionic Acid (2020-2028) ($MN)
  • Table 18 Global Eubiotics Market Outlook, By Essential Oil (2020-2028) ($MN)
  • Table 19 Global Eubiotics Market Outlook, By Enzymes (2020-2028) ($MN)
  • Table 20 Global Eubiotics Market Outlook, By Phytogenic (2020-2028) ($MN)
  • Table 21 Global Eubiotics Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 22 Global Eubiotics Market Outlook, By Form (2020-2028) ($MN)
  • Table 23 Global Eubiotics Market Outlook, By Liquid (2020-2028) ($MN)
  • Table 24 Global Eubiotics Market Outlook, By Solid (2020-2028) ($MN)
  • Table 25 Global Eubiotics Market Outlook, By Livestock (2020-2028) ($MN)
  • Table 26 Global Eubiotics Market Outlook, By Poultry (2020-2028) ($MN)
  • Table 27 Global Eubiotics Market Outlook, By Swine (2020-2028) ($MN)
  • Table 28 Global Eubiotics Market Outlook, By Ruminants (2020-2028) ($MN)
  • Table 29 Global Eubiotics Market Outlook, By Aquatic Animals (2020-2028) ($MN)
  • Table 30 Global Eubiotics Market Outlook, By Other Livestocks (2020-2028) ($MN)
  • Table 31 Global Eubiotics Market Outlook, By Application (2020-2028) ($MN)
  • Table 32 Global Eubiotics Market Outlook, By Immunity (2020-2028) ($MN)
  • Table 33 Global Eubiotics Market Outlook, By Gut Health (2020-2028) ($MN)
  • Table 34 Global Eubiotics Market Outlook, By Yield (2020-2028) ($MN)
  • Table 35 Global Eubiotics Market Outlook, By Nutrition (2020-2028) ($MN)
  • Table 36 Global Eubiotics Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 37 Global Eubiotics Market Outlook, By End User (2020-2028) ($MN)
  • Table 38 Global Eubiotics Market Outlook, By Poultry Feed (2020-2028) ($MN)
  • Table 39 Global Eubiotics Market Outlook, By Cattle Feed (2020-2028) ($MN)
  • Table 40 Global Eubiotics Market Outlook, By Swine Feed (2020-2028) ($MN)
  • Table 41 Global Eubiotics Market Outlook, By Aquatic Feed (2020-2028) ($MN)
  • Table 42 Global Eubiotics Market Outlook, By Other End Users (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.